These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10360715)

  • 1. A new sterile bicarbonate dialysis solution for use during cardiopulmonary bypass.
    Tobe SW; Murphy PM; Goldberg P; Harwood S; McLean R; Christakos G; Moldoveanu A; Purcell L
    ASAIO J; 1999; 45(3):157-9. PubMed ID: 10360715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: prospective cross-over comparison with a lactate buffered solution.
    Zimmerman D; Cotman P; Ting R; Karanicolas S; Tobe SW
    Nephrol Dial Transplant; 1999 Oct; 14(10):2387-91. PubMed ID: 10528662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dialysate potassium and lactate on serum potassium and bicarbonate concentrations during daily hemodialysis at low dialysate flow rates.
    Leypoldt JK; Kraus MA; Jaber BL; Weinhandl ED; Collins AJ
    BMC Nephrol; 2019 Jul; 20(1):252. PubMed ID: 31288787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated peritoneal dialysis with 'on-line'-prepared bicarbonate-buffered dialysate: technique and first clinical experiences.
    Brunkhorst R; Fromm S; Wrenger E; Berke A; Petersen R; Riede G; Westphale J; Zamore E; Ledebo I
    Nephrol Dial Transplant; 1998 Dec; 13(12):3189-92. PubMed ID: 9870487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better correction of metabolic acidosis, blood pressure control, and phagocytosis with bicarbonate compared to lactate solution in acute peritoneal dialysis.
    Thongboonkerd V; Lumlertgul D; Supajatura V
    Artif Organs; 2001 Feb; 25(2):99-108. PubMed ID: 11251475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zero balance ultrafiltration using dialysate during nationwide bicarbonate shortage: a retrospective analysis.
    Mullane R; Fristoe L; Markin NW; Brakke TR; Merritt-Genore HM; Siddique A; Miles CD; Plumb TJ
    J Cardiothorac Surg; 2019 Sep; 14(1):163. PubMed ID: 31500645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized long-term evaluation of bicarbonate-buffered CAPD solution.
    Feriani M; Kirchgessner J; La Greca G; Passlick-Deetjen J
    Kidney Int; 1998 Nov; 54(5):1731-8. PubMed ID: 9844152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of acetic acid for hydrochloric acid in the bicarbonate buffered dialysate.
    Fournier G; Potier J; Thébaud HE; Majdalani G; Ton-That H; Man NK
    Artif Organs; 1998 Jul; 22(7):608-13. PubMed ID: 9684700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
    Plum J; Schoenicke G; Grabensee B
    Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis.
    Dratwa M; Wilkie M; Ryckelynck JP; ter Wee PM; Rutherford P; Michel C; Hopwood A; Curtis L; Denys N; Divino Filho JC; Faict D;
    Kidney Int Suppl; 2003 Dec; (88):S105-13. PubMed ID: 14870884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction.
    McLean AG; Davenport A; Cox D; Sweny P
    Kidney Int; 2000 Oct; 58(4):1765-72. PubMed ID: 11012911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of bicarbonate dialysis during CAVHD.
    Jenkins RD; Jackson E; Kuhn R; Funk J
    ASAIO Trans; 1990; 36(3):M465-6. PubMed ID: 2252728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis: pilot study of single dialysis effects.
    Di Iorio B; Torraca S; Piscopo C; Sirico ML; Di Micco L; Pota A; Tartaglia D; Berardino L; Morrone LF; Russo D
    J Nephrol; 2012; 25(5):653-60. PubMed ID: 21983985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Zero-Balance Ultrafiltration With Dialysate as a Replacement Solution for Toxin and Eptifibatide Removal on a Dialysis-Dependent Patient During Cardiopulmonary Bypass.
    Heath M; Barbeito A; Welsby I; Maxwell C; Iribarne A; Raghunathan K
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):162-8. PubMed ID: 25857672
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma-Lyte 148 vs. Hartmann's solution for cardiopulmonary bypass pump prime: a prospective double-blind randomized trial.
    Weinberg L; Chiam E; Hooper J; Liskaser F; Hawkins AK; Massie D; Ellis A; Tan CO; Story D; Bellomo R
    Perfusion; 2018 May; 33(4):310-319. PubMed ID: 29144182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
    Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
    Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and complications of intraoperative hemodialysis during cardiopulmonary bypass with potassium-rich cardioplegia.
    Khoo MS; Braden GL; Deaton D; Owen S; Germain M; O'Shea M; Mulhern J; Rousou J; Flack J; Engleman R
    Am J Kidney Dis; 2003 Jun; 41(6):1247-56. PubMed ID: 12776278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Serum Bicarbonate Levels Caused by Acetate-Containing Bicarbonate-Buffered Hemodialysis Solution: An Observational Prospective Cohort Study.
    Panesar M; Shah N; Vaqar S; Ivaturi K; Gudleski G; Muscarella M; Lambert J; Su W; Murray B
    Ther Apher Dial; 2017 Apr; 21(2):157-165. PubMed ID: 28296160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-charged dialysate for children on hemodialysis: acute dialytic changes.
    Fischbach M; Terzic J; Bitoun Cohen C; Cousandier E; Hamel G; Battouche D; Geisert J
    Pediatr Nephrol; 1998 Jan; 12(1):60-2. PubMed ID: 9502570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.